NOTCH1 and idiopathic pulmonary fibrosis: Based on this information and the obtained promising results for the Notch1 inhibitor in mouse pulmonary fibrosis, we thus proposed that the Notch1 inhibitor may work as a potent drug candidate in treating IPF.